InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Neumora Therapeutics, Inc.

NMRA Clue Score21
United States Fiscal year ends December CIK 0001885522 Results filed 14 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Daljit Singh Aurora
21 Aug 2026
See Remarks
Sold after exercise indirect
21,055
$1.60
$33.60K
Daljit Singh Aurora
21 Aug 2026
See Remarks
Sold after exercise
20,553
$1.59
$32.78K
Daljit Singh Aurora
20 Aug 2026
See Remarks
Sold after exercise indirect
66,711
$1.51
$101.00K
Daljit Singh Aurora
20 Aug 2026
See Remarks
Sold after exercise
67,741
$1.51
$102.59K
Daljit Singh Aurora
19 Aug 2026
See Remarks
Sold after exercise indirect
30,918
$1.65
$50.89K
Daljit Singh Aurora
19 Aug 2026
See Remarks
Sold after exercise
31,000
$1.65
$51.03K
Daljit Singh Aurora
18 Aug 2026
See Remarks
Sold after exercise indirect
34,987
$1.59
$55.49K
Daljit Singh Aurora
18 Aug 2026
See Remarks
Sold after exercise
34,162
$1.58
$54.14K
Daljit Singh Aurora
17 Aug 2026
See Remarks
Sold after exercise indirect
55,016
$1.50
$82.78K
Daljit Singh Aurora
17 Aug 2026
See Remarks
Sold after exercise
34,020
$1.49
$50.53K
Daljit Singh Aurora
17 Aug 2026
See Remarks
Sold after exercise
57,670
$1.51
$86.82K
Matthew K Fust
18 Oct 2024
Director
Sold after exercise
14,049
$17.03
$239.32K
Matthew K Fust
17 Oct 2024
Director
Sold after exercise
7,739
$17.01
$131.64K
Show all 76 transactions →

What was left out

Form 4 filings counted 101
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 13
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 97,521,043
History held since 18 Sep 2023